Reliq Health Technologies Inc. (RQHTF)
OTCMKTS
· Delayed Price · Currency is USD
0.0003
0.00 (0.00%)
At close: Apr 30, 2025
Reliq Health Technologies Income Statement
Financials in millions CAD. Fiscal year is July - June.
Millions CAD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | 2013 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '23 Mar 31, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | Jun '19 Jun 30, 2019 | Jun '18 Jun 30, 2018 | 2013 - 2017 |
| Revenue | 14.62 | 8.55 | 1.46 | 1.14 | 0.18 | 2.27 | Upgrade
|
| Revenue Growth (YoY) | 119.37% | 484.87% | 27.92% | 528.36% | -91.98% | 1142.52% | Upgrade
|
| Cost of Revenue | 5.76 | 3.25 | 0.6 | 0.97 | 0.17 | 1.12 | Upgrade
|
| Gross Profit | 8.86 | 5.3 | 0.86 | 0.17 | 0.01 | 1.15 | Upgrade
|
| Selling, General & Admin | 5.27 | 4.94 | 7.07 | 7.7 | 6.2 | 4.29 | Upgrade
|
| Research & Development | 3.09 | 2.22 | 1.73 | 1.72 | 5.15 | 1.42 | Upgrade
|
| Operating Expenses | 10.19 | 13.52 | 12.42 | 11.33 | 13.31 | 14.78 | Upgrade
|
| Operating Income | -1.33 | -8.22 | -11.56 | -11.16 | -13.31 | -13.63 | Upgrade
|
| Interest Expense | -0.03 | -0.04 | -0.05 | -0.04 | - | - | Upgrade
|
| Interest & Investment Income | 0.47 | 0.08 | - | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | 0.49 | 0.08 | -0.1 | -0.02 | -0.02 | 0.02 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.06 | -0.07 | -0.08 | -0.07 | -0.08 | -0.16 | Upgrade
|
| EBT Excluding Unusual Items | -0.46 | -8.17 | -11.78 | -11.28 | -13.4 | -13.77 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | 0.16 | - | - | Upgrade
|
| Other Unusual Items | - | - | - | - | 0.4 | -0.03 | Upgrade
|
| Pretax Income | -0.46 | -8.17 | -11.78 | -11.12 | -13 | -13.8 | Upgrade
|
| Net Income | -0.46 | -8.17 | -11.78 | -11.12 | -13 | -13.8 | Upgrade
|
| Net Income to Common | -0.46 | -8.17 | -11.78 | -11.12 | -13 | -13.8 | Upgrade
|
| Shares Outstanding (Basic) | 186 | 183 | 158 | 135 | 118 | 95 | Upgrade
|
| Shares Outstanding (Diluted) | 186 | 183 | 158 | 135 | 118 | 95 | Upgrade
|
| Shares Change (YoY) | 0.89% | 15.96% | 16.77% | 14.19% | 24.13% | 59.30% | Upgrade
|
| EPS (Basic) | -0.00 | -0.04 | -0.07 | -0.08 | -0.11 | -0.14 | Upgrade
|
| EPS (Diluted) | -0.00 | -0.04 | -0.07 | -0.08 | -0.11 | -0.14 | Upgrade
|
| Free Cash Flow | -6.85 | -8.03 | -7.11 | -6.31 | -11.96 | -8.15 | Upgrade
|
| Free Cash Flow Per Share | -0.04 | -0.04 | -0.04 | -0.05 | -0.10 | -0.09 | Upgrade
|
| Gross Margin | 60.61% | 61.99% | 58.68% | 15.25% | 4.31% | 50.52% | Upgrade
|
| Operating Margin | -9.10% | -96.14% | -790.41% | -975.99% | -7314.43% | -600.72% | Upgrade
|
| Profit Margin | -3.13% | -95.55% | -805.69% | -973.06% | -7148.79% | -607.92% | Upgrade
|
| Free Cash Flow Margin | -46.87% | -93.88% | -485.99% | -551.82% | -6576.81% | -359.16% | Upgrade
|
| EBITDA | -1.21 | -8.11 | -11.48 | -10.82 | -12.67 | -13.63 | Upgrade
|
| EBITDA Margin | -8.27% | -94.79% | - | - | - | - | Upgrade
|
| D&A For EBITDA | 0.12 | 0.12 | 0.08 | 0.34 | 0.63 | 0 | Upgrade
|
| EBIT | -1.33 | -8.22 | -11.56 | -11.16 | -13.31 | -13.63 | Upgrade
|
| EBIT Margin | -9.10% | -96.14% | - | - | - | - | Upgrade
|
| Revenue as Reported | 14.62 | 8.55 | 1.46 | 1.14 | - | - | Upgrade
|
| Advertising Expenses | - | 0.49 | 0.51 | 0.28 | 0.27 | 0.38 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.